Fusion protein of adenovirus E4orf4 and human epidermal growth factor inhibits tumor cell growth

International Journal of Cancer

Volumn 125, Issue 5, 2009, Pages 1186-1192

  Zhou, Yu ^a   Chen, Hong ^a   Ma, Xiao Li ^a   Xie, Hai Jun ^a   Wang, Cun Lin ^a   Zhang, Sheng Hua ^b   Wang, Xin ^a   Huang, Bing Ren ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b INSTITUTE OF MEDICINAL BIOTECHNOLOGY   (China)

Author keywords

Cytotoxicity; E4orf4; Epidermal growth factor; Fusion protein; Selective targeting

Indexed keywords

CYCLOPHOSPHAMIDE; EARLY REGION 4 OPEN READING FRAME 4 PROTEIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; HYBRID PROTEIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER THERAPY; CELL GROWTH; CELL MIGRATION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG TARGETING; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUDE MOUSE; OPEN READING FRAME; PRIORITY JOURNAL; SINGLE DRUG DOSE; TUMOR GROWTH; TUMOR XENOGRAFT;

ADENOCARCINOMA; ANIMALS; BREAST NEOPLASMS; CELL PROLIFERATION; COLONY-FORMING UNITS ASSAY; EPIDERMAL GROWTH FACTOR; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MICE; MICE, INBRED BALB C; MICE, NUDE; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECOMBINANT FUSION PROTEINS; STOMACH NEOPLASMS; VIRAL PROTEINS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 67650045690     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24415     Document Type: Article

References (29)

1. Fickova M. Structure and activation of EGF receptor: minireview. Endocr Regul 2002;36:87-93.
2. Baselga J. Why the epidermal growth factor receptor? The rationale for cancer therapy. Oncologist 2002;7(Suppl 4):2-8.
3. Ciardiello F, Tortora G. A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor. Clin Cancer Res 2001;7:2958-70.
4. Liu TF, Cohen KA, Ramage JG, Willingham MC, Thorburn AM, Frankel AE. A diphtheria toxin-epidermal growth factor fusion protein is cytotoxic to human glioblastoma multiforme cells. Cancer Res 2003;63:1834-7.
5. Uckun FM, Narla RK, Zeren T, Yanishevski Y, Myers DE, Waurzyniak B, Ek O, Schneider E, Messinger Y, Chelstrom LM, Gunther R, Evans W. In vivo toxicity, pharmacokinetics, and anticancer activity of Genistein linked to recombinant human epidermal growth factor. Clin Cancer Res 1998;4:1125-34.
6. Thomas SM, Zeng Q, Epperly MW, Gooding WE, Pastan I, Wang QC, Greenberger J, Grandis JR. Abrogation of head and neck squamous cell carcinoma growth by epidermal growth factor receptor ligand fused to pseudomonas exotoxin transforming growth factor alpha-PE38. Clin Cancer Res 2004;10:7079-87.
7. Lavoie JN, Nguyen M, Marcellus RC, Branton PE, Shore GC. E4orf4, a novel adenovirus death factor that induces p53-independent apoptosis by a pathway that is not inhibited by zVAD-fmk. J Cell Biol 1998;140:637-45.
8. Shtrichman R, Kleinberger T. Adenovirus type 5 E4 open reading frame 4 protein induces apoptosis in transformed cells. J Virol 1998;72:2975-82.
9. Shtrichman R, Sharf R, Barr H, Dobner T, Kleinberger T. Induction of apoptosis by adenovirus E4orf4 protein is specific to transformed cells and requires an interaction with protein phosphatase 2A. Proc Natl Acad Sci 1999;96:10080-5.
10. Marcellus RC, Chan H, Paquette D, Thirlwell S, Boivin D, Branton PE. Induction of p53-independent apoptosis by the adenovirus E4orf4 protein requires binding to the Ba subunit of protein phosphatase 2A. J Virol 2000;74:7869-77.
11. Kornitzer D, Sharf R, Kleinberger T. Adenovirus E4orf4 protein induces PP2A-dependent growth arrest in Saccharomyces cerevisiae and interacts with the anaphase-promoting complex/cyclosome. J Cell Biol 2001;154:331-44.
12. Roopchand DE, Lee JM, Shahinian S, Paquette D, Bussey H, Branton PE. Toxicity of human adenovirus E4orf4 protein in Saccharomyces cerevisiae results from interactions with the Cdc55 regulatory B subunit of PP2A. Oncogene 2001;20:5279-90.
13. Li Y, Wei H, Hsieh TC, Pallas DC. Cdc55p-mediated E4orf4 growth inhibition in Saccharomyces cerevisiae is mediated only in part via the catalytic subunit of protein phosphatase 2A. J Virol 2008;82:3612-23.
14. Lavoie JN, Champagne C, Gingras MC, Robert A. Adenovirus E4 open reading frame 4-induced apoptosis involves dysregulation of Src family kinases. J Cell Biol 2000;150:1037-55.
15. Gingras MC, Champagne C, Roy M, Lavoie JN. Cytoplasmic death signal triggered by Src-mediated phosphorylation of the adenovirus E4orf4 protein. Mol Cell Biol 2002;22:41-56.
16. Robert A, Smadja-Lamère N, Landry MC, Champagne C, Petrie R, Lamarche-Vane N, Hosoya H, Lavoie JN. Adenovirus E4orf4 hijacks rho GTPase-dependent actin dynamics to kill cells: a role for endosome-associated actin assembly. Mol Biol Cell 2006;17:3329-44.
17. Mitrus I, Missol-Kolka E, Plucienniczak A, Szala S. Tumour therapy with genes encoding apoptin and E4orf4. Anticancer Res 2005;25:1087-90.
18. Bu PL, Wang DM, Chen H, Huang BR. Expression of epidermal growth factor-adenovirus E4orf4 fusion protein in tumor cells and its cytotoxicity. Ai Zheng 2005;24:33-9.
19. Wang DM, Zhou Y, Xie HJ, Ma XL, Wang X, Chen H, Huang BR. Cytotoxicity of a recombinant fusion protein of adenovirus early region 4 open reading frame 4 (E4orf4) and human epidermal growth factor on p53-deficient tumor cells. Anticancer Drugs 2006;17:527-37.
20. Deng GR, Lu YY, Chen SM, Miao J, Lu GR, Li H, Cai H, Xu XL, E Z, Liu PN. Activated c-Ha-ras oncogene with a guanine to thymine transversion at the twelfth codon in a human stomach cancer cell line. Cancer Res 1987;47:3195-8.
21. Bishop N, Horman A, Woodman P. Mammalian class E vps proteins recognize ubiquitin and act in the removal of endosomal protein-ubiquitin conjugates. J Cell Biol 2002;157:91-101.
22. Doyotte A, Russell MR, Hopkins CR, Woodman PG. Depletion of TSG101 forms a mammalian ''Class E'' compartment: a multicisternal early endosome with multiple sorting defects. J Cell Sci 2005;118:3003-17.
23. Maddika S, Mendoza FJ, Hauff K, Zamzow CR, Paranjothy T, Los M. Cancer-selective therapy of the future: apoptin and its mechanism of action. Cancer Biol Ther 2006;5:10-9.
24. Livne A, Shtrichman R, Kleinberger T. Caspase activation by adenovirus e4orf4 protein is cell line specific and is mediated by the death receptor pathway. J Virol 2001;75:789-98.
25. Robert A, Miron MJ, Champagne C, Gingras MC, Branton PE, Lavoie JN. Distinct cell death pathways triggered by the adenovirus early region 4 ORF 4 protein. J Cell Biol 2002;158:519-28.
26. Liu TF, Hall PD, Cohen KA, Willingham MC, Cai J, Thorburn A, Frankel AE. Interstitial diphtheria toxin-epidermal growth factor fusion protein therapy produces regressions of subcutaneous human glioblastoma multiforme tumors in athymic nude mice. Clin Cancer Res 2005;11:329-34.
27. Burke P, Schooler K, Wiley HS. Regulation of epidermal growth factor receptor signaling by endocytosis and intracellular trafficking. Mol Biol Cell 2001;12:1897-910.
28. Yoon JM, Han SH, Kown OB, Kim SH, Park MH, Kim BK. Cloning and cytotoxicity of fusion proteins of EGF and angiogenin. Life Sci 1999;64:1435-45.
29. Jinno H, Ueda M, Ozawa S, Ikeda T, Kitajima M, Maeda T, Seno M. The cytotoxicity of a conjugate composed of human epidermal growth factor and eosinophil cationic protein. Anticancer Res 2002;22:4141-6.